HER2/neu-directed therapy for biliary tract cancer

被引：0
|
作者：
Milind Javle
Chaitanya Churi
HyunSeon C. Kang
Rachna Shroff
Filip Janku
Rakesh Surapaneni
Mingxin Zuo
Christian Barrera
Humaid Alshamsi
Sunil Krishnan
Lopa Mishra
Robert A. Wolff
Ahmed O. Kaseb
Melanie B. Thomas
Abby B. Siegel
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine
[2] The University of Texas MD Anderson Cancer Center,Department of Diagnostic Radiology, Division of Diagnostic Imaging
[3] The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics, Division of Cancer Medicine
[4] Scott & White Clinic,Department of Radiation Oncology, Division of Radiation Oncology
[5] The University of Texas MD Anderson Cancer Center,Department of Gastroenterology
[6] The University of Texas MD Anderson Cancer Center,Departments of Medicine and Surgery
[7] Gibbs Cancer Center & Research Institute,undefined
[8] Columbia University,undefined
来源：
Journal of Hematology & Oncology | / 8卷
关键词：
Receptor; ErbB-2; Gallbladder neoplasms; Cancer of the biliary tract;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA
    Paudyal, Bishnuhari
    Zhang, Kaijun
    Chen, Chang-Po
    Wampole, Matthew E.
    Mehta, Neil
    Mitchell, Edith P.
    Gray, Brian D.
    Mattis, Jeffrey A.
    Pak, Koon Y.
    Thakur, Mathew L.
    Wickstrom, Eric
    NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (08) : 994 - 999
  • [22] The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein
    Li, HB
    Sánchez-Torres, J
    del Carpio, A
    Salas, V
    Villalobo, A
    BIOCHEMICAL JOURNAL, 2004, 381 : 257 - 266
  • [23] Her2/neu expression by reverse transcriptase-polymerase chain reaction in the peripheral blood of prostate cancer patients
    Fantinato, Ana Paula
    Tobias-Machado, Marcos
    Fonseca, Fernando
    Pinto, Jorge Luiz Freire
    Wroclawski, Marcelo Langer
    Wroclawski, Eric
    Verotti, Mauricio
    del Giglio, Auro
    TUMORI JOURNAL, 2007, 93 (05): : 467 - 472
  • [24] Differences in axillary response and treatment implications in HER2 positive node positive breast cancer during neoadjuvant HER2 targeted dual therapy
    Mou, Exian
    Ji, Juan
    Liu, Shiwei
    Shu, Lan
    Zou, Liqun
    Li, Zhuoxuan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [25] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
  • [26] Cone-beam breast CT features associated with HER2/neu overexpression in patients with primary breast cancer
    Zhu, Yueqiang
    Zhang, Yuwei
    Ma, Yue
    Li, Haijie
    Liu, Aidi
    Han, Peng
    Yin, Lu
    Lv, Nan
    Li, Zhijun
    Lu, Hong
    Liu, Peifang
    Ye, Zhaoxiang
    EUROPEAN RADIOLOGY, 2020, 30 (05) : 2731 - 2739
  • [27] Quartz Crystal Microbalance (QCM) Based Biosensor Functionalized by HER2/neu Antibody for Breast Cancer Cell Detection
    Yilmaz, Merve
    Bakhshpour, Monireh
    Gokturk, Ilgim
    Piskin, Ayse Kevser
    Denizli, Adil
    CHEMOSENSORS, 2021, 9 (04)
  • [28] Adjuvant therapy for resected biliary tract cancer: a review
    Doherty, Mark K.
    Knox, Jennifer J.
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (05)
  • [29] HER2 Fragmentation and Breast Cancer Stratification
    Arribas, Joaquin
    Lluis Parra-Palau, Josep
    Pedersen, Kim
    CLINICAL CANCER RESEARCH, 2010, 16 (16) : 4071 - 4073
  • [30] Decreased Survival of Human Breast Cancer Cells Expressing HER2/neu on In vitro Incubation with an Anti-HER2/neu Antibody Fused to C5a or C5adesArg
    Fuenmayor, Jaheli
    Perez-Vazquez, Karin
    Perez-Witzke, Daniel
    Penichet, Manuel L.
    Montano, Ramon F.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (08) : 2175 - 2185
12345